Tissue/Organ

Exclusive: Complex organoids from stem cells

Lab-grown organs similar to normal tissue and superior to previous structures. Scientists at the University of Würzburg recently announced they have successfully produced human tissues...

Novoheart and AstraZeneca develop heart in a jar

AstraZeneca and Novoheart have combined forces to develop a first of its kind model for a common, but much misunderstood form of heart failure. Pharma...

Rejuvenation: If I could turn back time …

Bioquark looks to nature for the answers to regeneration and rejuvenation. Last week, the BBC reported on the plight of axolotls in Mexico City, which...

Meet Peter 2.0: One step closer to the Singularity

When Dr Peter Scott-Morgan was diagnosed with motor neurone disease, he decided to challenge what it means to be human. “Peter 2.0 is now online.”...

Latest articles

CMS to invest £25m in UK start-ups

A collaboration between AstraZeneca, Cambridge Judge and Chinese pharmaceutical company CMS aims to close the funding gap for biotech and life sciences start-ups in...

AgeX and Lineage granted pluripotent patent

AgeX Therapeutics and Lineage Cell Therapeutics awarded U.S. patent for 'Method of Generating Induced Pluripotent Stem Cells'. AgeX Therapeutics, Inc. and Lineage Cell Therapeutics, Inc. today announced...

Artificial neurons created on microchip

A major breakthrough for neural technology as scientists reproduce the electrical properties of neurons on a semiconductor chip. Researchers at Bath have made a world...

Longevity stocks: Go public with caution

SENS chief warns Longevity companies on perils of floating too soon. There is no doubt that the Longevity market is starting to take off. But...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.